#BIO2022 is back in person - San Diego June 13-16. Join us for limitless possibilities at the largest gathering of the #biotech industry.
https://t.co/mwiuPNMUiz
Paul Hastings, President & CEO of Nkarta Therapeutics, @nkartatx, shares his approach for an equitable workforce on today’s Good Day BIO Live: https://t.co/mKvZjSuKke
We've enjoyed bringing the biotech community together again to celebrate their life saving work that allowed us to gather in person. Thanks to all who attended #BIO2022!
Venus Williams shared how her diagnosis of Sjogren's syndrome is like a “box of chocolates.” Hear more of her interview with Erin Andrews on today’s Good Day BIO Live: https://t.co/nxIsHshi9T
Today's Good Day BIO Live! features exclusive interviews with BIO leadership and policy experts on AMR, Accelerated Approval, and the patient experience—plus a few clips of Venus Williams and a mother with a powerful patient story. Watch now. https://t.co/2z0VfgeFql
Today's Good Day BIO Live looks at what happened at #BIO2022 yesterday with a look on what to expect today. Watch at the link below. https://t.co/9yOR1kdRTy
Hear an in-depth discussion on the importance of the Prescription Drug User Fee Act (PDUFA) VII and potential new policies needed to provide a pathway for innovative new treatment. Sponsored by @TravereRare. #BIO2022#SuperSession https://t.co/YR732ZwlXA
Hear from a panel of industry leaders, investors, and government representatives about the challenges in innovation for AMR. #BIO2022 https://t.co/ZqdmpevqPV
"I hope we're sitting here ten years from now saying clinical trials are an antiquated way of capturing clinical data."
CEO of @IAmBiotech, @DrMichelleBIO, shares her outlook on clinical trials in the latest episode of Breakthrough Economy.
Learn more: https://t.co/1ndfe3iyJd
As the world’s largest advocacy association representing member companies, we make the impossible, possible. Learn more about us at https://t.co/lsmUgNyuxo
Happening at #BIO2022: James A. Geraghty joined Paul Hastings of @nkartatx to discuss Geraghty’s new book, which explores the origin of the Orphan Drug Act and the impact nearly 40 years later. https://t.co/H85Cdupwru
Join today's discussion to learn more about the Accelerated Approval pathway and the impact these therapies have had on patients’ lives. #BIO2022 https://t.co/OOu76p9upg
Panelists will share insights to maximize global partnerships and alliances to reduce clinical, regulatory, manufacturing, and distribution challenges for the next global pandemic. Sponsored by @Novavax. #BIO2022#SuperSession https://t.co/tUvnHD1lSn